Selected article for: "cc NC International license and sensitivity analysis"
Author: Francisca Verdugo-Paiva; Ariel Izcovich; Martin Ragusa; Gabriel Rada
Title: Lopinavir/ritonavir f?or the treatment of COVID-19: A living systematic review protocol
  • Document date: 2020_4_17
    • ID: mhi6w4mr_27
    Snippet: We will include trials assessing participants with COVID-19, as defined by the authors of the trials. If substantial clinical heterogeneity on how the condition was defined is found, we will explore it using a sensitivity analysis. 5 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: We will include trials assessing participants with COVID-19, as defined by the authors of the trials. If substantial clinical heterogeneity on how the condition was defined is found, we will explore it using a sensitivity analysis. 5 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and participant assess: 1
    • cc NC ND International license and sensitivity analysis: 1, 2, 3, 4, 5, 6
    • clinical heterogeneity and sensitivity analysis: 1, 2, 3, 4, 5, 6
    • clinical heterogeneity and sensitivity analysis explore: 1, 2
    • condition define and International license: 1
    • International license and participant assess: 1
    • International license and sensitivity analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13